Who Exports Ribavirin from India — 50 Suppliers Behind a $646.4K Market
India's ribavirin export market is supplied by 50 active exporters who collectively shipped $646.4K across 165 shipments. AUROBINDO PHARMA LTD leads with a 80.6% market share, followed by AUROBINDO PHARMA LIMITED and KWALITY PHARMACEUTICALS LIMITED. The top 5 suppliers together control 92.1% of total export value, reflecting a concentrated market structure.
Top Ribavirin Exporters from India — Ranked by Export Value
AUROBINDO PHARMA LTD is the leading ribavirin exporter from India, holding a 80.6% share of the $646.4K market across 165 shipments from 50 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, KWALITY PHARMACEUTICALS LIMITED, EXSELL LABORATORIES PRIVATE LIMITED, STAR ENTERPRISES — collectively control 92.1% of total export value, indicating a highly concentrated market. Individual shares are: AUROBINDO PHARMA LTD (80.6%), AUROBINDO PHARMA LIMITED (5.8%), KWALITY PHARMACEUTICALS LIMITED (2.4%), EXSELL LABORATORIES PRIVATE LIMITED (2.4%), STAR ENTERPRISES (0.9%).
Top Ribavirin Exporters from India
Ranked by export value · 50 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD RIBAVIRIN TABLETS USP 200MG 3456 X 168 S PACKRIBAVIRIN TABLETS 200MG168'SRIBAVIRIN TABLETS USP 200 MG | $521.1K | 3 | 80.6% |
| 2 | AUROBINDO PHARMA LIMITED RIBAVIRIN TABLETS USP 200MG 3456 X 168 S PACKRIBAVIRIN TABLETS 200MG168'SRIBAVIRIN TABLETS USP 200 MG | $37.5K | 3 | 5.8% |
| 3 | KWALITY PHARMACEUTICALS LIMITED RIBAVIRIN CAPSULES 400 MG. (RIBAVIRIN INJECTION 50MG/MLRIBAVIRIN CAPSULES USP 400 MG (BATH NO | $15.7K | 3 | 2.4% |
| 4 | EXSELL LABORATORIES PRIVATE LIMITED RIBAVIRIN CAPSULES 200MG | $15.2K | 2 | 2.4% |
| 5 | STAR ENTERPRISES RIBASURE 200 CAP ,PACK | $6.0K | 1 | 0.9% |
| 6 | GALAXY SUPER SPECIALITY | $3.7K | 2 | 0.6% |
| 7 | MUNANI PHARMACEUTICALS PRIVATE LIMITED RIBASURE 200 CAP ,PACK | $2.5K | 1 | 0.4% |
| 8 | MUNANI PHARMACEUTICALS RIBASURE 200 CAP ,PACK | $1.6K | 1 | 0.3% |
| 9 | RUTVA MEDICARE RIBASURE 200 CAP ,PACK | $1.4K | 2 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ribavirin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter (January 2 | Yes | Yes | 1,585 | Received FDA Warning Letter in January 2022 for Unit I; holds WHO-GMP and EU-GMP |
| Kwality Pharmaceuticals Limited | Not Listed | Yes | Yes | Not verified | Achieved EU-GMP certification for its Himachal Pradesh facility in April 2023; h |
TransData Nexus reviewed the regulatory standing of 2 leading Ribavirin exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ribavirin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often termed the "Bulk Drug Capital of India," is a central hub for active pharmaceutical ingredient (API) manufacturing. Aurobindo Pharma Limited, headquartered here, exemplifies this with its vertically integrated operations, encompassing API production and formulation development. The city's infrastructure and skilled workforce have fostered a conducive environment for large-scale API manufacturing, contributing significantly to India's pharmaceutical exports.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts numerous formulation units that specialize in producing finished dosage forms, including tablets and capsules. The presence of well-established manufacturing facilities and a robust regulatory framework has made this cluster a key player in the formulation segment of the pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a strategic export gateway for pharmaceutical products. Proximity to major ports facilitates efficient distribution channels, enabling companies to export products like Ribavirin to international markets. The region's well-developed logistics infrastructure supports the seamless movement of pharmaceutical goods, reinforcing its role as a critical node in the supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units, enhancing production capacities and contributing to the overall growth of the industry.
5Sourcing Recommendations
- Diversify Supplier Base: While Aurobindo Pharma Limited is a major supplier, consider engaging with other manufacturers in different clusters to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize the API manufacturing capabilities of Hyderabad and the formulation expertise of the Ahmedabad-Vadodara region to optimize production processes.
- Optimize Logistics: Capitalize on the export infrastructure of the Mumbai-Thane-Raigad belt to ensure timely and efficient distribution of Ribavirin to international markets.
- Explore Incentive Zones: Assess the benefits of manufacturing in tax incentive zones like Baddi-Nalagarh to potentially reduce production costs.
By strategically engaging with these pharmaceutical clusters, companies can enhance their supply chain resilience and capitalize on India's robust pharmaceutical manufacturing ecosystem.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ribavirin exporters from India
Aurobindo Pharma Ltd — Aurobindo Pharma acquires Khandelwal Labs' non-oncology business
Aurobindo Pharma's subsidiary, Auro Pharma Ltd, acquired the non-oncology prescription formulations business of Khandelwal Laboratories for ₹325 crore. The acquisition includes 23 brands across 67 SKUs and nine pipeline products, primarily in anti-infective and pain management segments. - IMPACT: This acquisition is expected to strengthen Aurobindo's domestic market presence but is unlikely to directly impact Ribavirin exports.
Impact: This acquisition is expected to strengthen Aurobindo's domestic market presence but is unlikely to directly impact Ribavirin exports.
Aurobindo Pharma Ltd — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing
TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration focuses on biologics and does not directly affect Ribavirin exports.
Impact: This collaboration focuses on biologics and does not directly affect Ribavirin exports.
Aurobindo Pharma Ltd — Aurobindo Pharma acquires Apotex's businesses in five European countries
Aurobindo Pharma signed a definitive agreement to acquire Apotex's commercial operations in Poland, the Czech Republic, the Netherlands, Spain, and Belgium, expanding its European footprint. - IMPACT: This acquisition enhances Aurobindo's European presence but does not directly impact Ribavirin exports.
Impact: This acquisition enhances Aurobindo's European presence but does not directly impact Ribavirin exports.
Common Questions — Ribavirin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ribavirin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 28 recorded shipments worth $521.1K. AUROBINDO PHARMA LIMITED (6 shipments) and KWALITY PHARMACEUTICALS LIMITED (7 shipments) are also established high-volume exporters.
Q How many ribavirin manufacturers are there in India?
India has 50 active ribavirin exporters with a combined export market of $646.4K across 165 shipments to 32 countries. The top 5 suppliers hold 92.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ribavirin from India?
Average FOB unit price: $8.51 per unit, ranging from $0.06 to $55.91. Average shipment value: $3.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 50 verified Indian exporters of Ribavirin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 165 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 32 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
165 Verified Shipments
50 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists